Pollen-related seasonal allergic rhinoconjunctivitis (SAR) is a very frequent pediatric disease in westernized countries. Risk factors and disease phenotypes have been thoroughly examined in several cross-sectional studies. By contrast, only a few studies have examined disease evolution in patient cohorts. We investigated predictive biomarkers of disease evolution in a large cohort of children with SAR.
Cipriani, F., Tripodi, S., Panetta, V., Perna, S., Potapova, E., Dondi, A., et al. (2019). Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort. PEDIATRIC ALLERGY AND IMMUNOLOGY, 30(3), 325-334 [10.1111/pai.13036].
Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort
Cipriani, FrancescaWriting – Original Draft Preparation
;Dondi, Arianna;Gallucci, Marcella;Giannetti, Arianna;Ricci, Giampaolo
Conceptualization
;
2019
Abstract
Pollen-related seasonal allergic rhinoconjunctivitis (SAR) is a very frequent pediatric disease in westernized countries. Risk factors and disease phenotypes have been thoroughly examined in several cross-sectional studies. By contrast, only a few studies have examined disease evolution in patient cohorts. We investigated predictive biomarkers of disease evolution in a large cohort of children with SAR.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
